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Abstract 
Background: The results of existing studies regarding the use of neuromodulation in fecal 
incontinence (FI) are contradictory and therefore, a definitive conclusion cannot be made in this 
regard. Therefore, the aim of the present study was to evaluate the effectiveness of neuromodulation 
in controlling FI in children through a systematic review.. 
Materials and Methods: A decision was made to perform the search in electronic databases of 
Medline, Embase, Web of Science, CINAHL and Scopus until end of October 2017. In the second 
step, the abstracts of the extracted studies were evaluated by 2 researchers independently and recorded 
in the data extraction form. Finally, all studies were summarized and categorized based on the 
evaluated outcomes and overall effect size was presented.  
Results: Five studies were included in the present meta-analysis (including 115 children and 
adolescent). Pooled analysis also showed that the odds of improvement in the group under treatment 
with nerve stimulation was up to 20 times higher (OR = 20.29; 95% CI: 8.67 to 47.45; p<0.0001). In 
addition, using nerve stimulation leads to a significant improvement in fecal incontinence score of 
patients (SMD = 2.32; 95% CI: 1.12 to 3.52; p<0.0001).  
Conclusion: It can be concluded that neuromodulation can seemingly be an effective measure in 
controlling FI in children. However, the lack of standard clinical trials in this field is highly felt and it 
is suggested to assess the effect of neuromodulation on FI by performing blinded randomized clinical 
trials in future studies.  
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1- INTRODUCTION 
     Fecal incontinence (FI) is a common 
and important disorder among pelvic floor 
disorders, which brings about a 
complicated situation and deeply impacts 
personal health, mental status, and quality 
of life in affected individuals (1). The 
incidence of mental and social problems 
following FI in children is significantly 
higher than adults. This has a big impact 
not only the individual but also the child’s 
family (2, 3). FI in children is defined as 
involuntary passing of stool in underwear 
(in children over 4 years old), and occurs 
due to functional (such as constipation, 
prolapse, inflammatory bowel disease and 
neuropathy), or organic causes (such as 
anorectal malformation, 
Hirschsprung's (HIRSH-sproongz) disease, 
spinal cord injury, cerebral palsy and 
myopathy) (4). The prevalence of FI in 
children of western countries is 0.8% to 
4.1% (5-8). However, recent studies in 
Asia have shown that in Iran, South Korea 
and Sri Lanka the prevalence is 2% to 
7.8% (9-11).  
The first line of treatment mainly includes 
medication, biofeedback and therapeutic 
regimen (12, 13). The second line of 
treatment includes surgery such as 
 sphincteroplasty (14), bulking agents (15), 
artificial sphincter (16), and recently, 
regeneration of damaged sphincter muscle 
tissue using stem cells (17, 18) just like 
this method is used for regeneration of 
other tissues (19-26). Applying less 
invasive therapeutic strategies for 
management of FI is more acceptable 
because Forte et al. have recently shown 
that, contrary to the current belief, surgery 
is not necessarily the most effective 
treatment for FI (27). One of these less 
invasive methods is using 
neuromodulation, such as Sacral Nerve 
Stimulation (SNS), which was among the 
first non-surgical techniques applied for 
treatment of FI. Today, SNS is considered 
as the second line of treatment in patients 
who have not responded to drug therapy, 
biofeedback, and etc. Neuromodulation 
probably results in the control of FI 
symptoms by affecting the somatosensory-
cortical centres of the anus (28, 29). 
Limitations such as the mentioned 
therapeutic method being expensive on 
one hand and need for a skilled and expert 
operator or therapist on the other has 
resulted in this therapeutic method being 
unavailable in many instances and this has 
prevented it from being widely used in 
clinic. The results of existing studies 
regarding the use of neuromodulation in FI 
are contradictory and therefore, a 
definitive conclusion cannot be made in 
this regard. One of the ways that a general 
conclusion can be made regarding the 
effectiveness of using peripheral nerve 
stimulation in treating FI is performing a 
systematic review and meta-analysis on 
the existing studies in this field. Therefore, 
the aim of the present study is to evaluate 
the effectiveness of neuromodulation in 
controlling FI in children through a 
systematic review. 
2- MATERIALS AND METHODS 
2-1. Study design and search strategy 
    The present study is a systematic review 
in which the effect of SNS on FI in 
children and adolescents has been 
evaluated. This study has been designed 
based on Cochrane guideline for 
performing meta-analysis on clinical trials. 
Patients with FI in the age range of 1 to 19 
years were considered. In the beginning of 
the study, search strategy was designed. 
By consulting a librarian who was familiar 
with databases, a decision was made to 
perform the search in electronic databases 
of Medline, Embase, Web of Science, 
CINAHL and Scopus. Search was done to 
find the studies published until end of 
October 2017. To do the search, first 
keywords including words related to "fecal 
incontinence" and "neuromodulation" were 
selected. Keywords were selected as broad 
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as possible in order to avoid omission of 
relevant studies. Keywords and their 
combination method in databases have 
been presented in Table.1 (Please see the 
table in the end of paper). To find 
additional articles or unpublished data, a 
hand-search was also carried out in the list 
of relevant study references and related 
journals. In addition, three strategies were 
considered for searching in gray literature. 
First, search was performed in the thesis 
section of ProQuest. Second, attempts 
were made to contact corresponding 
authors of related articles in order to 
access unpublished data or in-press 
articles. Finally, Google and Google 
Scholar search engines were used to find 
additional resources. In cases where the 
data could not be extracted from the 
article, authors of the articles were 
contacted. If the corresponding author did 
not respond to the first email, a reminder 
email was sent to the author. If there was 
still no response a second reminder was 
sent (with 1 week interval). If the author 
did not respond in the third attempt, other 
authors of the article were contacted via 
social media such as Research gate and 
LinkedIn to provide the required data for 
the researchers.  
2-2. Inclusion and exclusion criteria  
In this study, randomized clinical trials or 
quasi experimental studies that evaluated 
the effect of neuromodulation on FI were 
included. The study population was 
selected to include children and 
adolescents with FI from both sexes. 
Studies lacking a control group and those 
in which the status of FI was not evaluated 
were excluded. It should be noted that 
review articles were also excluded. 
2-3. Quality assessment and data 
extraction 
Data collection method, summarization 
and quality control of articles have been 
reported in previous studies by the 
researchers (30-50). In summary, the 
results of search in the literature were 
combined and duplicate studies were 
eliminated using EndNote software. In the 
second step, the abstracts of the extracted 
studies were evaluated by 2 researchers 
independently and recorded in the data 
extraction form and in case of being 
excluded, the reason was mentioned. In 
case of disagreement between the 2 
researchers, a third reviewer studied the 
findings and by discussing it with the 2 
researchers the disagreement was resolved. 
The systematic search results were 
recorded in a checklist that was designed 
based on the guidelines of PRISMA 
statement (51). This checklist included 
data related to article characteristics (name 
of the first author and year of publication), 
sample characteristics (age, gender), 
number of studied samples, baseline 
characteristics of the patients, duration of 
follow-up, treatment protocol, evaluated 
outcomes and probable bias. When the 
mentioned values were not reported in a 
study, the corresponding author was asked 
to provide them for the researchers. 
Quality status of each study was evaluated 
using the Cochran guideline for human 
studies. 
2-4. Data analysis 
All studies were summarized and 
categorized based on the evaluated 
outcomes. Heterogeneity between the 
studies was evaluated using chi square and 
I2 tests, and p-value less than 0.1 were 
considered significant (indicating 
heterogeneity). Results of the studies were 
pooled and an overall effect size was 
presented. Funnel Plot and Egger's test and 
Begg's tests were used for evaluating 
publication bias (52). Statistical analyses 
were performed by STATA version 14.0 
(Stata Corporation, College Station, TX). 
3- RESULTS 
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3-1. Summary of included studies 
     The systematic and manual search 
conducted in this study yielded 4,352 non-
redundant records. After the initial 
screening and receiving full-text of the 
articles, 15 papers were studied in more 
detail and finally, 5 studies were included 
(53-57) (Figure.1). Four studies had a 
before-after design and one study had 
cross-over clinical trial design. In these 
studies, a total of 115 children and 
adolescents with FI who had not responded 
to common treatments underwent 
treatment with neuromodulation. The 
neuromodulation used was implanted 
sacral nerve stimulation in three studies 
(54, 56, 57), transcutaneous external-
neuromyogenic electrostimulation in 1 
study (53), and transcutaneous posterior 
tibial nerve stimulation  in another one 
(55). Protocol of nerve stimulation was not 
fully described in most studies. Only one 
study had reported all three factors of 
nerve stimulation frequency, session 
duration and session number (55). 
Duration of follow-up ranged between 4.5 
and 30 months. The evaluated outcomes 
included resting pressure, maximum 
squeezing pressure, incontinence score and 
success rate (Table.2) (Please see the 
table in the end of paper). 
 
 
Fig.1: PRISMA flowchart of present study. 
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3-2. Risk of bias 
There was a high risk of bias regarding 
allocation concealment, blinding of 
patients and researchers and blinding of 
outcome assessing in all studies. The status 
of selective reporting and other bias was 
unclear in all studies (Figure.2). In 
addition, publication bias was not observed 
in the present study (Figure.3) (Please see 
the figures in the end of paper). 
3-3. Meta-analysis 
3-3-1. Success rate of neuromodulation 
in treatment of FI 
The success rate reported in the study is 
shown in Figure 4-A. As can be seen, all 
studies have expressed that the success rate 
of nerve stimulation in were higher before 
intervention or the control group. Pooled 
analysis also showed that the odds of 
improvement in the group under treatment 
with nerve stimulation was up to 20 times 
higher (odds ratio [OR]= 20.29; 
95% confidence interval [95% CI]: 8.67 to 
47.45; p<0.0001). 
3-3-2. Fecal incontinence score 
Data from four papers were included in 
analyzes of this section (53-57). This 
section of analyzes included 79 children 
under treatment with nerve stimulation. 
The findings indicated a significant 
heterogeneity in this section (I2=87.2%; 
p<0.0001). Therefore, a random-effect 
model was used to pool the data. As 
Figure 4-B shows, using nerve stimulation 
leads to a significant improvement in fecal 
incontinence score of patients 
(standardized mean difference 
[SMD]=2.32; 95% CI: 1.12 to 3.52; 
p<0.0001). In other words, using this 
therapeutic technique can improve the 
status of stool control in children and 
adolescents. 
4- DISCUSSION 
     The results of the present systematic 
review and meta-analysis on the role of 
neuromodulation in controlling FI in 
children indicate that this treatment 
method increases the success rate of fecal 
continence up to 20 times and also 
significantly increases standard fecal 
incontinence score compared to before 
treatment. These results indicate the 
effectiveness of neuromodulation for 
controlling FI in children. The results of 
the present meta-analysis are in line with 
those of the systematic reviews performed 
in adults in this regard. In 2004, Jarrett et 
al. performed a systematic review on 106 
studies and its results showed that SNS 
significantly improves FI, and shows some 
degree of improvement regarding 
constipation (58). In 2008, in a systematic 
review on FI and constipation, Mowatt et 
al. stated that despite the effectiveness of 
SNS in controlling FI, more studies are 
needed to reach a definitive conclusion 
(59). In a systematic review evaluating the 
mechanism of SNS in the control of FI and 
constipation in 2014, while demonstrating 
the efficacy of SNS in controlling fecal 
incontinence, Carrington et al. expressed 
that the common belief that SNS 
mechanism of action occurs in the 
anorectal level is seemingly wrong and the 
location of action for SNS in controlling FI 
is in the higher levels of the central 
nervous system (60).  
In 2015, Thomas et al. as well as Thaha et 
al. performed systematic reviews and 
concluded that to reach a more accurate 
conclusion regarding the role of SNS in 
controlling FI after surgery and 
radiotherapy, more studies are needed (61, 
62). Despite the numerous studies on SNS 
mechanism of action in controlling FI, the 
exact mechanism is unknown. Evidence 
suggests that the third sacral foramen is the 
best level for SNS induction, although 
second and third sacral foramina are also 
used. SNS effects are related to stimulation 
of the sacral nerve root adjacent to the 
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corresponding sacral foramen. In addition 
to stimulating the nerve root, part of the 
sympathetic chain that is adjacent to the 
sacral foramen is also stimulated. A sacral 
nerve contains motor, sensory and 
autonomic fibers (sympathetic and 
parasympathetic), and during SNS all of 
these fibers are stimulated. The first fibers 
that are stimulated during SNS are alpha 
motor fibers that innervate the external 
anal sphincter (EAS) and levator ani (63-
66); thus, increasing the contractile force 
of the EAS can be a logical reason for 
improvement and success in stool control. 
After the motor fibers, the sensory fibers 
that innervate the anal canal are 
stimulated. These fibers play a key role in 
sensory-motor reflexes, which are 
important in optimal performance of the 
anal canal (67). Therefore, modulating 
these reflexes via SNS can be part of SNS 
mechanism of action in controlling FI. 
Balance in activity of autonomous nerves 
is a key factor in colorectal health and 
optimal performance of the internal anal 
sphincter (IAS) (68). Therefore, changing 
this balance and affecting IAS function can 
also be part of SNS mechanism of action 
in controlling FI. 
4-1. Limitation 
In general, existing systematic reviews as 
well as the present systematic review 
express that the small number of studies, 
presence of bias, and high heterogeneity in 
the performed studies are obstacles to 
reaching a conclusion regarding the 
effectiveness of this treatment method in 
treatment and management of FI. In 
addition, most of the studies included in 
this study had a before-after design, which 
is also one of the limitations that prevent 
reaching a reliable final conclusion in this 
regard. Therefore, in the end, this study 
suggests that the final conclusions can be 
reached after further clinical trials. Many 
of the included studies have low quality, 
which definitely makes comparing the 
studies difficult. 
5- CONCLUSIONS 
    From the results of the present 
systematic review, it can be concluded that 
neuromodulation can seemingly be an 
effective measure in controlling FI in 
children. However, the lack of standard 
clinical trials in this field is highly felt and 
it is suggested to assess the effect of 
neuromodulation on FI by performing 
blinded randomized clinical trials in future 
studies.  
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   Table-1: Search query in Medline, Embase and Scopus databases 
Database Search query 
Medline 
(("Fecal Incontinence"[Mesh] OR "Fecal Incontinence"[tiab] OR “Fecal Incontinences”[tiab] OR “Incontinence, Fecal”[tiab] OR “Incontinences, 
Fecal”[tiab] OR “anal incontinence”[tiab] OR “ anus incontinence”[tiab] OR “ bowel incontinence”[tiab] OR “ encopresis”[tiab] OR “ faecal 
incontinence”[tiab] OR “ faeces incontinence”[tiab] OR “ fecal incontinence”[tiab] OR “ fecal incontinency”[tiab] OR “ incontinence, anal”[tiab] 
OR “ incontinentia alvi”[tiab])) AND ("Transcutaneous Electric Nerve Stimulation"[Mesh] OR “Transcutaneous Electric Nerve Stimulation”[tiab] 
OR “Percutaneous Electric Nerve Stimulation”[tiab] OR “TENS”[tiab] OR “Electrical Stimulation, Transcutaneous”[tiab] OR “Stimulation, 
Transcutaneous Electrical”[tiab] OR “Transcutaneous Electrical Stimulation”[tiab] OR “Transdermal Electrostimulation”[tiab] OR 
“Electrostimulation, Transdermal”[tiab] OR “Percutaneous Electrical Nerve Stimulation”[tiab] OR “Transcutaneous Electrical Nerve 
Stimulation”[tiab] OR “Electric Stimulation, Transcutaneous”[tiab] OR “Stimulation, Transcutaneous Electric”[tiab] OR “Transcutaneous Electric 
Stimulation”[tiab] OR “Transcutaneous Nerve Stimulation”[tiab] OR “Nerve Stimulation, Transcutaneous”[tiab] OR “Stimulation, Transcutaneous 
Nerve”[tiab] OR “Analgesic Cutaneous Electrostimulation”[tiab] OR “Cutaneous Electrostimulation, Analgesic”[tiab] OR “Electrostimulation, 
Analgesic Cutaneous”[tiab] OR “Electroanalgesia”[tiab] OR “Neuromodulation”[tiab] OR “sacral nerve stimulation”[tiab] OR “sacral nerve 
modulation”[tiab] OR “nerve stimulation”[tiab]). 
Embase 
('neuromodulation'/exp OR 'sacral nerve stimulation'/exp OR 'sacral nerve modulation'/exp OR 'nerve stimulation'/exp OR 'transcutaneous electrical 
nerve stimulation'/exp) AND ('feces incontinence'/exp OR 'fecal leakage'/exp). 
Scopus 
1- ( TITLE-ABS-KEY ( "Fecal Incontinence" )  OR  TITLE-ABS-KEY ( "Fecal Incontinence" )  OR  TITLE-ABS-KEY ( “Fecal Incontinences” )  
OR  TITLE-ABS-KEY ( “Incontinence, Fecal” )  OR  TITLE-ABS-KEY ( “Incontinences, Fecal” )  OR  TITLE-ABS-KEY ( “anal incontinence” )  
OR  TITLE-ABS-KEY ( “ anus incontinence” )  OR  TITLE-ABS-KEY ( “ bowel incontinence” )  OR  TITLE-ABS-KEY ( “ encopresis” )  OR  
TITLE-ABS-KEY ( “ faecal incontinence” )  OR  TITLE-ABS-KEY ( “ faeces incontinence” )  OR  TITLE-ABS-KEY ( “ fecal incontinence” )  
OR  TITLE-ABS-KEY ( “ fecal incontinency” )  OR  TITLE-ABS-KEY ( “ incontinence, anal” )  OR  TITLE-ABS-KEY ( “ incontinentia alvi” ) ). 
2- ( TITLE-ABS-KEY ( "Transcutaneous Electric Nerve Stimulation" )  OR  TITLE-ABS-KEY ( “Transcutaneous Electric Nerve Stimulation” )  
OR  TITLE-ABS-KEY ( “Percutaneous Electric Nerve Stimulation” )  OR  TITLE-ABS-KEY ( “TENS” )  OR  TITLE-ABS-KEY ( “Electrical 
Stimulation, Transcutaneous” )  OR  TITLE-ABS-KEY ( “Stimulation, Transcutaneous Electrical” )  OR  TITLE-ABS-KEY ( “Transcutaneous 
Electrical Stimulation” )  OR  TITLE-ABS-KEY ( “Transdermal Electrostimulation” )  OR  TITLE-ABS-KEY ( “Electrostimulation, Transdermal” 
)  OR  TITLE-ABS-KEY ( “Percutaneous Electrical Nerve Stimulation” )  OR  TITLE-ABS-KEY ( “Transcutaneous Electrical Nerve Stimulation” 
)  OR  TITLE-ABS-KEY ( “Electric Stimulation, Transcutaneous” )  OR  TITLE-ABS-KEY ( “Stimulation, Transcutaneous Electric” )  OR  
TITLE-ABS-KEY ( “Transcutaneous Electric Stimulation” )  OR  TITLE-ABS-KEY ( “Transcutaneous Nerve Stimulation” )  OR  TITLE-ABS-
KEY ( “Nerve Stimulation, Transcutaneous” )  OR  TITLE-ABS-KEY ( “Stimulation, Transcutaneous Nerve” )  OR  TITLE-ABS-KEY ( 
“Analgesic Cutaneous Electrostimulation” )  OR  TITLE-ABS-KEY ( “Cutaneous Electrostimulation, Analgesic” )  OR  TITLE-ABS-KEY ( 
“Electrostimulation, Analgesic Cutaneous” ) OR  TITLE-ABS-KEY ( “Electroanalgesia” )  OR  TITLE-ABS-KEY ( “Neuromodulation” )  OR  
TITLE-ABS-KEY ( “sacral nerve stimulation” )  OR  TITLE-ABS-KEY ( “sacral nerve modulation” )  OR  TITLE-ABS-KEY ( “nerve 
stimulation” ) ). 
3- #1 AND #2 
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Transcutaneous external neuromyogenic 
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Lu; 2017 (56) Before-
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   NR: Not reported; SNS: Sacral nerve stimulation; PTNS: Posterior tibial nerve stimulation; n= number; min: minute. 
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Fig.2: Assessment of risk of bias through eligible studies. 
Neuromodulation in Fecal Incontinence 

























0 2 4 6
Log odds ratio














-2 -1 0 1 2 3
Log SMD
Funnel plot with pseudo 95% confidence limits
 






Sarveazad et al. 
Int J Pediatr, Vol.5, N.12, Serial No.48, Dec. 2017                                                                                                                                                                                               6577 
 
 
 Fig.4: Forrest plot for the success rate of neuromodulation in treatment of fecal incontinence (A) and effect of this treatment modality on fecal incontinence 
score (B) in pediatrics patients. CI: Confidence interval; OR: Odds ratio; SMD: Standardized mean differences.  
